Samir Sabbag, MD
Geriatric Psychiatry · Monterey, CANPI 1669620654
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,450 of the $14,840 with a category attached, or 63.7%. AbbVie accounts for 74.3% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $6,893 and has fallen 63.3% since, to $2,527 in 2025. Among geriatric psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $47.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Axsome Therapeutics, Inc.$616
- Otsuka America Pharmaceutical, Inc.$613
- Johnson & Johnson$407
- Teva Pharmaceuticals USA, Inc.$400
- Lundbeck LLC$392
- plus $1K from 10 others
What the payments were for
- Speaking & faculty fees$9,45064%
- Food & beverage$5,16735%
- Education$2232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 86 | $11,019 |
| Axsome Therapeutics, Inc. | 26 | $616 |
| Otsuka America Pharmaceutical, Inc. | 59 | $613 |
| Johnson & Johnson | 36 | $407 |
| Teva Pharmaceuticals USA, Inc. | 10 | $400 |
| Lundbeck LLC | 17 | $392 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $370 |
| Alkermes, Inc. | 11 | $306 |
| Neurocrine Biosciences, Inc. | 12 | $257 |
| Sunovion Pharmaceuticals Inc. | 9 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $123 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Tris Pharma Inc | 3 | $49 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,840 in reported general payments places this provider in the 90th percentile of 46 geriatric psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 19 | $11,014 |
| Aripiprazole | 24 | $5,304 |
| Lisdexamfetamine Dimesylate | 12 | $2,446 |
| Vilazodone Hcl | 17 | $1,118 |
| Duloxetine Hcl | 33 | $1,020 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $990 |
| Quetiapine Fumarate | 11 | $816 |
| Lamotrigine | 26 | $765 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $608 |
| Mirtazapine | 24 | $555 |
| Lorazepam | 50 | $443 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $424 |
| Ramelteon | 12 | $415 |
| Sertraline Hcl | 23 | $377 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $321 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Monterey
- David SultzerLos Angeles$203K
- Kristine YaffeSan Francisco$40K
- James NelsonSan Francisco$31K
- Harsukh SavaliaCerritos$9K
- Barbara HuynhLos Angeles$4K
- Phillip GrobSanta Rosa$3K
- Jasdeep AulakhPatton$3K
- Kyle BechazLos Angeles$1K
- Beverly ChangRoseville$842
- Izzet YazganCapitola$785
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.